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Thyroid hormones are key regulators of cellular growth, development, and metabolism, and thyroid disorders are a common cause of ill
health in the community. Circulating concentrations of thyrotropin (TSH), thyroxine (T4) and triiodothyronine (T3) have a strong heri-
table component and are thought to be under polygenic control, but the genes responsible are mostly unknown. In order to identify
genetic loci associated with these metabolic phenotypes, we performed a genome-wide association study of 2,120,505 SNPs in 2014
female twins from the TwinsUK study and found a significant association between rs10917469 on chromosome 1p36.13 and serum
TSH (p ¼ 3.2 3 108). The association of rs10917469 with serum TSH was replicated (p ¼ 2.0 3 104) in an independent commu-
nity-based sample of 1154 participants in the Busselton Health Study. This SNP is located near CAPZB, which might be a regulator of
TSH secretion and thus of pituitary-thyroid axis function. Twenty-nine percent of white individuals carry the variant, and the difference
in mean TSH concentrations between wild-type individuals and those homozygous for the minor G allele was 0.5 mU/l, which is likely
to be clinically relevant. We also provide evidence of suggestive association (p < 5.03 106) of other SNPs with serum TSH, free T4, and
free T3 concentrations, and these SNPs might be good targets for further studies. These results advance understanding of the genetic
basis of pituitary-thyroid axis function and metabolic regulation.Acting on almost every tissue in the body, thyroid
hormones affect basal metabolic rate, protein synthesis,
fat and carbohydrate metabolism, and cellular response
to catecholamines. They are essential to development
and cellular differentiation in a range of tissues, as demon-
strated by the severe clinical consequences of untreated
congenital hypothyroidism [MIM #218700]. Clinically,
one evaluates pituitary-thyroid axis function bymeasuring
circulating concentrations of thyrotropin (TSH), free
thyroxine (T4), and free triiodothyronine (T3). TSH and
T4 have an inverse, log-linear relationship such that small
changes in free T4 levels result in large changes in TSH
secretion, making TSH the most sensitive marker of
thyroid dysfunction.1 In healthy subjects, TSH, free T4,
and free T3 concentrations show considerable differences
between individuals (inter-individual variation), whereas
variability is much less in the same individual sampled
repeatedly over a prolonged period of time (intra-indi-
vidual variation).2 This suggests that individuals have
different set points (individual means) for pituitary-
thyroid axis function. Twin and family studies have shown
that these set points are under strong genetic influence;
heritability estimates are up to 65% for variation in serum
TSH, free T4, and free T3.3–5 This could be clinically impor-
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Thyroid disease is an important public health problem in
that it affects up to 10% of the population.
At present, little is known about which genes regulate
pituitary-thyroid axis set points, and given the complexity
of hypothalamo-pituitary-thyroid physiology, a large
number of candidate genes exist. Thus far, only two
single-nucleotide polymorphisms (SNPs) have been shown
with convincing significance and rigorous replication to be
associated with differences in circulating concentrations of
TSH or thyroid hormones: one SNP is in the phosphodies-
terase 8B gene PDE8B (MIM þ603390) (associated with
TSH),13 and one is in the iodothyronine deiodinase 1
gene DIO1 (MIM þ147892) (associated with the T4/T3
ratio).14 These SNPs account for only a small proportion
of phenotypic variance, and it seems likely that other regu-
latory genes remain to be identified for TSH, free T4, and
free T3.
To investigate this further, we undertook a genome-wide
association study (GWAS) to attempt to identify genetic
loci that influence serum TSH, free T4, and free T3 concen-
trations in healthy twins, and we replicated the key result
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Table 1. Characteristics of the Two Cohorts
Twins UK
Busselton
(Replication Cohort)
Number 2,014 1,154
Female (percent) 100 51.9
Age (years) 46.4 (12.4) 59.4 (14.3)
BMI (kg/m2) 25.2 (4.7) 26.4 (4.1)
TSH (mU/liter) 1.5 (0.8) 1.8 (2.1)
Free T4 (pmol/liter) 13.7 (1.7) 16.6 (3.4)
Free T3 (pmol/liter) 3.9 (0.6) 4.0 (0.9)
Percent TPOAb þve 16.9% 16.5%
Mean (SD) is given unless otherwise stated.The discovery cohort consisted of 2,456 female twins of
European descent (2035 dizygotic and 421 monozygotic),
aged 18 to 80 years, from St Thomas’ UK Adult Twin
Registry (TwinsUK), a volunteer sample recruited through
a national media campaign in the United Kingdom
without selection for particular diseases or traits.15
Zygosity was determined by a standard questionnaire
and by multiplex DNA fingerprinting with variable
tandem repeats as well as concordance of genome-wide
genotyping. Serum TSH, free T4, free T3, and thyroid
peroxidase antibodies (TPOAb) were measured by chemilu-
minescence immunoassay with the Abbott Architect
analyzer (Abbott Diagnostics, North Ryde, Australia). After
exclusion of participants with a history of thyroid disease,
those taking medications likely to influence serum thyroid
function (such as anticonvulsants or oral glucocorticoids),
and those with biochemical evidence of clinically signifi-
cant thyroid dysfunction (defined as serum TSH < 0.1 or
> 10 mU/liter), the study cohort consisted of 2364 partic-
ipants. Genotyping was carried out via the Infinium assay
(Illumina, San Diego, USA) with a combination of fully
compatible SNP arrays (Hap300, Hap550 and Hap610).
We pooled together the normalized intensity data for
genomic DNA samples and used the Illluminus geno-
type-calling algorithm to assign genotypes. No calls were
assigned if an individual’s most likely call had a posterior
probability less than 0.95. Validation of pooling was
achieved via a visual inspection of 100 random, shared
SNPs for overt batch effects; none were observed. We
excluded subjects on the basis of the genotype data
when (1) the SNP call rate was < 90% and (2) when there
was evidence of non-European ancestry as determined by
application of the STRUCTURE program.16 We imputed
~2.5 million HapMap phase II (Build 36/hg18) SNPs for
each participant by using IMPUTE software and used the
‘‘proper info’’ output variable to determine imputation
quality. Only SNPs with an imputation quality value
R 0.4 were retained in the analysis. We employed addi-
tional quality criteria to filter imputed SNPs: p < 1 3
106 in a test for deviation from Hardy-Weinberg equilib-
rium (1,169 SNPs), minor allele frequency (MAF) < 1%
(143,873 SNPs), and SNP call rate < 90% (295,759 SNPs).
We thus retained 2,120,505 SNPs for analysis. The final
study cohort with complete SNP data and thyroid function
consisted of 2014 individuals.
The replication cohort consisted of 1154 participants in
the 1994-5 Busselton Health Study. This is a cross-sectional
health survey of inhabitants of a rural town in Western
Australia with a predominantly white, iodine-sufficient
population; details of the cohort have been published
previously.17 Serum TSH, free T4, free T3, and TPOAb
were measured with an Immulite 2000 chemiluminescent
analyzer (Diagnostic Products Corporation, Los Angeles,
California). The exclusion criteria above were applied,
and the result was a disease-free cohort of 1093 subjects.
We attempted replication of eight SNPs selected from the
GWAS results on the basis of the observed level of statis-The Americantical significance and biological plausibility of genes in
the locus. These SNPs were as follows: for TSH,
rs10917469, rs13383344, rs1527680, and rs6030171; for
free T4, rs211811, rs1908679, and rs7285004; and for
free T3, rs10493251. The genotype for each SNP was deter-
mined via TaqMan allelic discrimination 50 nuclease assays
(Applied Biosystems, Foster City, CA) in a reaction volume
of 5 ml containing assay-specific primers and allele-specific
probes according to the manufacturer’s protocol. Fluores-
cence was measured by a Victor2 Multilabel Plate-Reader
(Perkin-Elmer, Waltham, MA). Informed consent was ob-
tained from each individual, and the study was approved
by the local ethics committee.
Association testing of the thyroid phenotypes TSH, FT4,
and FT3 was conducted with the GenABEL18 suite of pro-
grammes. We applied the inverse normal transform to all
phenotypes to achieve a normal distribution. Prior to anal-
ysis, phenotypes were adjusted for factors—age, sex (for
the replication cohort only), positive TPO antibody status,
and body mass index (BMI) —known to be associated with
thyroid function. For the TwinsUK group, we used the
quantitative-traits score test based on the method of
Chen and Abecasis19 and implemented in GenABEL,
which accounts for the relatedness between individuals
from the same family. In the replication cohort, the
selected SNPs were analyzed with the score test of Aul-
chenko et al.20 Descriptive statistics for both study groups
were given as mean and standard deviation for continuous
variables or percentages for categorical variables. All statis-
tical analysis was performed in the R statistical computing
environment, version 2.10.1.21
The clinical and demographic characteristics of partici-
pants in each cohort are shown in Table 1. Figure 1 shows
the results of the GWAS by chromosome for TSH, free T4,
and free T3. The strongest association with TSH was for
rs10917469 at chromosome 1p36.13, and this result was
significant (p ¼ 3.2 3 108; Figure 2) at a genome-wide
significance threshold of p < 5.0 3 108. This SNP is
located in a linkage disequilibrium (LD) block extending
~47 kb. Numerous other SNPs that we genotyped in thatJournal of Human Genetics 87, 430–435, September 10, 2010 431
Figure 1. Manhattan Plots from GWAS of Serum TSH, Free T4,
and Free T3 in the Discovery Cohort
A value of p < 5.0 3 108 is regarded as significant. For each
marker, the log10 of the p value resulting from an association
test that evaluates its additive effect on the phenotype is plotted.
Figure 2. Association of SNPs at Chromosome 1p36.13 with
Serum TSH in the Discovery Cohort and LD Structure, D0, of the
Region on the Basis of HapMap CEU Datagenomic location showed a strong association with serum
TSH levels in the GWAS (Figure 2), and this LD block is
located approximately 10 kb upstream of the transcription
start site of CAPZB (MIM *601572). NBL1 (MIM *600613)
and C1orf151 are also located in this genomic region.
Each G allele of rs10917469 was associated with a decrease
in serum TSH concentrations. For free T4, the strongest
association was with rs211811 on chromosome 7q31.1
(p ¼ 3.3 3 107); the nearest gene is IMMP2L (MIM
*605977), a mitochondrial inner-membrane peptidase
located approximately 220 kb downstream. The SNP most432 The American Journal of Human Genetics 87, 430–435, Septembstrongly associated with serum-free T3 was rs10493251
(p ¼ 5.8 3 107), which is in the vicinity of DAB1
(MIM *603448) at chromosome 1p32.2. None of these
SNPs are in genetic loci that were previously known to be
associated with thyroid hormone levels. Associations with
suggestive significance of p< 5.03 106 for each parameter
are shown in Table S1. QQ plots of serum TSH, free T4, and
free T3 are displayed in Figures S1, S2, and S3, respectively.
Of the provisional genetic associations with thyroid
phenotypes that we selected for attempted replication in
the Busselton cohort (Table S2), only one was confirmed:
SNP rs10917469, located on chromosome 1p36.13 and
associated with serum TSH. Table 2 shows that the associ-
ation between rs10917469 genotype and serum TSH
concentrations was similar in each cohort. After adjust-
ment for relevant covariates, the difference in mean serum
TSH concentration between the wild-type AA genotype
and the alternative homozygote GG genotype was
0.5 mU/liter in the TwinsUK cohort and 0.4 mU/liter in
the Busselton Health Study. Serum free T4 and free T3
concentrations did not differ significantly between indi-
viduals grouped by genotype. The total variance in TSH
that is explained by rs10917469 after for other relevant
covariates (age, TPOAb status, BMI and where appropriate,
gender) are accounted for was 1.3% in the TwinsUK cohort
and 1.0% in the Busselton cohort.er 10, 2010
Table 2. Association of rs10917469 with TSH in the Discovery and
Replication Cohorts
Cohort n A/A A/G G/G
freq
(G)
beta
(SE) p Value
Twins UK 2006 1.5 (0.9) 1.4 (0.8) 1.0 (0.5) 0.16 0.16
(0.03)
3.2 3 108
Busselton 1049 2.0 (1.2) 1.9 (1.2) 1.6 (0.8) 0.15 0.23
(0.06)
2.0 3 104
Data are adjusted for sex, age, BMI, and TPOAb positivity. Values for each
genotype are the mean (standard deviation) of TSH in mU/liter.In the TwinsUK cohort, analysis of rs4704397 in PDE8B,
the SNP previously reported as being associated with
TSH,13 showed an association of p ¼ 2.6 3 103 and a
per-allele effect size of 0.048 mU/liter. In our data this
SNP explained 0.4% of the variance in TSH. Analysis of
rs2235544 in DIO1, the SNP previously reported as being
associated with free T4,14 showed an association of
p¼ 9.43 104 and a per-allele effect size of 0.18 pmol/liter,
which explained 0.5% of the variance. These effect sizes
are smaller than those reported in the original studies;
however, the p values are consistent with the size of the
cohort and effect sizes commonly reported for SNPs associ-
ated with multifactorial traits. Allowing for differences in
the characteristics and exclusion criteria applied to the
original study cohorts and this one, replication of these
associations in our GWAS is reassuring about the validity
of our findings.
The SNP rs10917469 is located upstream of CAPZB,
which is not known to be involved in thyroid function.
CAPZB encodes the beta subunit of the barbed-end actin-
binding protein, a member of the F-actin-capping protein
family. These proteins bind to the fast-growing (‘‘barbed’’)
ends of the actin filament blocking the exchange of
subunits and regulating growth. Gene expression data
(Unigene Hs.432760) reveals high levels of expression in
normal thyroid compared with other tissues in humans
and moderate expression in the brain and pituitary,
making it biologically plausible that the gene regulates
pituitary-thyroid axis function, although precisely how it
does this is not known. Possible cellular pathways
affected include cell-cycle spindle assembly, cytoskeleton
remodeling, and assembly of cytoplasmic microtubules.
The follicular architecture of the thyroid gland is impor-
tant in thyroid physiology and is commonly disturbed in
thyroid disease.22 Organization of thyroid epithelial cells
into structures enclosing colloid-filled lumena facilitates
the synthesis and secretion of thyroid hormones and
allows for this production to be coupled to a store of
hormonal precursors.22 Morphogenetic events including
the coordinated action of cellular adhesion, intracellular
trafficking, and precise regulation of morphogenetic cell
movements are needed to create functional follicles.
Furthermore, TSH acting through the cAMP-protein kinase
A signaling pathway has been identified as a principal
determinant of thyroid follicular morphology in vitro.22The AmericanTherefore, a potential mechanism could involve sensitivity
of thyrocytes to TSH and a response to cues embodied by
cell shape, cytoskeletal tension, and actin nucleation and
branching experienced in the adult context; this requires
further study. The SNP rs10917469 is also located in the
region of NBL1. The protein product of NBL1 is reported
to act as an antagonist for bone morphogenetic proteins
by binding to them and preventing interaction with their
receptors; therefore, the gene might play a role in growth
and development.
SNP rs10917469 on chromosome 1p36.13 is only the
second SNP—the other being rs4704397 in PDE8B13—
convincingly shown to be associated with serum TSH
concentrations. Each SNP accounts for only about 1% of
population variance in serum TSH; this most likely reflects
a polygenic influence on hormone variation. Other genes
with small effects are likely to be discovered as larger study
populations are used for GWAS. Despite this apparently
modest effect, the difference of 0.5 mU/liter in mean
serum TSH between wild-type and an alternative homozy-
gote genotype for rs10917469 is likely to be clinically rele-
vant. In population-based studies, small differences in
serum TSH of the order of 0.5 to 1.0 mU/liter are associated
with significant differences in blood pressure,9 choles-
terol,10 BMI,6–8 risk of atrial fibrillation23 and cardiovas-
cular mortality.12 Furthermore, a comparable difference
of 0.4 mU/liter between genotypes of the rs4704397 SNP
in PDE8B has been shown to impact the diagnosis of
subclinical hypothyroidism in pregnant women.24 Further
research is required to establish the contribution of these
SNPs to clinically relevant health outcomes.
Strengths of our study include its large and well-charac-
terized discovery cohort, detailed assessment (including
measurements of free T4, free T3, and TPOAb) of pitui-
tary-thyroid thyroid axis function, exclusion of partici-
pants with clinically relevant thyroid disease, and replica-
tion of the key finding in a separate, well-characterized
cohort. A limitation of the study is that the replication
cohort was of modest size, potentially reducing its power
to replicate weaker associations from the discovery cohort.
Using the Genetic Power Calculator software,25 we esti-
mated that in the replication study at an a ¼ 0.01, for vari-
ants explaining 1% of the trait variance and where the SNP
is the quantitative trait nucleotide, the power is 0.80.
However, if the proportion of the trait variance explained
is lower, then the power of the replication study would
be less. In addition, although we did attempt replication
of what we considered the eight most biologically credible
GWAS hits identified from the discovery cohort, this is
a relatively small number of the SNPs. Study of a greater
number of the top-ranked associationsmight have resulted
in the confirmation of additional associations. Finally,
although the SNP rs10917469 is close to CAPZB, which is
expressed in human thyroid and pituitary tissue, it
remains a possibility that the association observed with
TSH is due to regulatory effects on another gene in this
genomic region via linkage disequilibrium. FurtherJournal of Human Genetics 87, 430–435, September 10, 2010 433
mapping studies of this locus and functional studies of
CAPZB will be needed to clarify this detail.
In conclusion, we report the results of GWA scan for
TSH, free T4, and free T3 in healthy individuals. We have
identified a common variant that is close to CAPZB and
is associated with serum TSH concentrations, and we repli-
cated that finding in an independent cohort. We also
report a number of other SNPs associated with these
parameters in the discovery cohort, and these SNPs might
warrant further study in other cohorts or meta-analyses of
existing cohorts.Supplemental Data
Supplemental Data include three figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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